The influence of clozapine and typical neuroleptics on information processing of the central nervous system under clinical conditions in schizophrenic disorders: Implications for fitness to drive

Neuropsychobiology

Volumn 40, Issue 4, 1999, Pages 196-201

  Grabe, Hans Jörgen ^a   Wolf, T ^b   Gratz S ^c   Laux, G ^d  

^a UNIVERSITY OF GREIFSWALD   (Germany)

^b Abt Psychiat und Psychotherapie   (Germany)

^c Klin Psychiat Psychotherapie U   (Germany)

^d Bezirkskrankenhaus Garbersee ^*  (Germany)

Author keywords

Clozapine; Fitness to drive; Neuroleptics; Sensorimotor performance

Indexed keywords

AMISULPRIDE; ANTIDEPRESSANT AGENT; CHLORPROTHIXENE; CLOZAPINE; FLUPENTIXOL; HALOPERIDOL; HYPNOTIC AGENT; LITHIUM; NEUROLEPTIC AGENT; PERAZINE; VALPROIC ACID;

ADULT; ALERTNESS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRIVING ABILITY; FEMALE; HUMAN; INFORMATION PROCESSING; MALE; PRIORITY JOURNAL; PSYCHOMOTOR PERFORMANCE; REACTION TIME; SCHIZOPHRENIA; STRESS; VISION;

ADULT; ANTIPSYCHOTIC AGENTS; ATTENTION; AUTOMOBILE DRIVING; CLOZAPINE; FEMALE; GERMANY; HUMANS; MALE; MENTAL PROCESSES; POLYPHARMACY; PSYCHOMOTOR PERFORMANCE; REACTION TIME; SCHIZOPHRENIA; VISUAL PERCEPTION;

EID: 0032721437     PISSN: 0302282X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000026619     Document Type: Article

References (20)

1. Nuechterlein KH, Dawson ME: Information processing and attentional functioning in the developmental course of schizophrenic disorders. Schizophr Bull 1984;10:160-193.
2. Harvey PD, Walker E, Wielgus MS: Psychological markers of vulnerability to schizophrenia: Research and future directions. Prog Exp Pers Res 1986;14:231-267.
3. Nuechterlein KH: Vigilance in schizophrenia and related disorders; in Steinhauer SR, Gruzelier HJ, Zubin J (eds): Handbook of Schizophrenia. Amsterdam, Elsevier, 1991, vol 5, pp 397-433.
4. Maier W, Franke P, Hain C, Kopp B, Rist F: Neuropsychological indicators of the vulnerability to schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 1992;16:703-715.
5. Maier W, Franke P, Kopp B, Hardt J, Hain C, Rist F: Reaction time paradigms in subjects at risk for schizophrenia. Schizophr Res 1994;13: 35-43.
6. Rösler F, Stieglitz RD, Manzey D: Flupentixolhydrochloride in low dosages: Effects on perceptual and psychomotor performance in emotionally stable and emotionally labile healthy subjects. Neuropsychobiology 1986;16:27-36.
7. Spohn HE, Lacoursière RB, Thompson K, Coyne L: Phenotiazine effects on psychological and psychophysiological dysfunction in chronic schizophrenics. Arch Gen Psychiatry 1977; 34:633-644.
8. Verdoux H, Magnin E, Bourgeois M: Neuroleptic effects on neuropsychological test performance in schizophrenia. Schizophr Res 1995; 14:133-139.
9. Guebel-Mathyl U: Effects of neuroleptics on aspects relevant to driving fitness; in O'Hanlon JF, deGier JJ (eds): Drugs and Driving. London, Taylor & Francis, 1986, pp 241-247.
10. Guebel-Mathyl U: Zum Problem der Fahrtüchtigkeit unter neuroleptischer Therapie - Eine klinisch-psychologische Untersuchung aus der Rheinischen Landesklinik, und der Bundesanstalt für Strassenwesen. Unfall und Sicherheitsforschung. Strassenverkehr 1987;60:16-21.
11. Hobi V: Psychopharmaka und Fahrtauglichkeit; in Riederer P, Laux G, Pöldinger W (eds): Neuro-Psychopharmaka. Wien, Springer, 1992, vol 1, pp 335-352.
12. Juul Povlsen VJ, Noring U, Fog R, Gerlach J: Tolerability and therapeutic effect of clozapine. Acta Psychiatr Scand 1985;71:176-185.
13. Kane J, Honigfeld G, Singer J, Melzer HY: The clozaril collaborative study group: Clozapine for the treatment-resistant schizophrenic: A double-blind comparison with clorpromazine. Arch Gen Psychiatry 1988;45:789-796.
14. Hagger C, Buckley P, Kenny JT, Freedman L, Ubogy D, Melzer HY: Improvement of cognitive functions and psychiatric symptoms in treatment refractory schizophrenic patients receiving clozapine. Biol Psychiatry 1993;34: 702-712.
15. Buchanan W, Holstein C, Breier A: The comparative efficacy and longterm effect of clozapine treatment on neuropsychological test performance. Biol Psychiatry 1994;36:717-725.
16. Goldberg TI, Greenberg RD, Griffin SJ, Gold JM, Kleinman JE, Pickar D, Schulz SC, Weinberger DR: The effect of clozapine on cognition and psychiatric symptoms in patients with schizophrenia. Br J Psychiatry 1993;162:43-48.
17. Classen W, Laux G: Sensorimotor and cognitive performance of schizophrenic inpatients treated with haloperidol, flupentixol or clozapine. Pharmaccpsychiatry 1988;21:295-297.
18. Dilling H, Mombour W, Schmidt MH (eds): Internationale Klassifikation psychischer Störungen: ICD-10, Kapitel V (F), klinisch-diagnostische Leitlinien, Weltgesundheitsorganisation. Bern, Huber, 1991.
19. Risser R, Schmidt L, Brandstätter C, Bukasa B, Wenninger U: Verkehrspsychologische Testverfahren und Kriterien des Fahrverhaltens. Wien, Verkehrspsychologisches Institut des Kuratoriums für Verkehrssicherheit, 1993.
20. Bukasa B, Kisser R, Wenninger U: Computer-gestützte Leistungsdiagnostik bei verkehrspsychologischen Eignungsuntersuchungen. Diagnostica 1990;36:148-165.